Welcome to our dedicated page for GE Aerospace news (Ticker: GE), a resource for investors and traders seeking the latest updates and insights on GE Aerospace stock.
GE Aerospace (NYSE: GE) is a global aerospace propulsion, services, and systems company with an installed base of tens of thousands of commercial and military aircraft engines. The GE news feed on Stock Titan highlights official announcements, customer agreements, technology collaborations, and capital markets disclosures that shape the company’s role in aviation.
News items often feature engine selection and purchase agreements with airlines and aviation groups for families such as GEnx and GE9X, including orders that cover engines, spare units, and long-term services support. These stories provide insight into how airlines are planning fleet growth, widebody expansion, and long-haul route development using GE Aerospace propulsion.
Investors and aviation followers will also find coverage of service and leasing partnerships, such as lease pool management arrangements for GE9X, GEnx, GE90, CF6, and CF34 engines. These updates explain how GE Aerospace and its partners manage shop visits, lease returns, and technical support to keep fleets operating reliably.
The news stream includes technology and innovation updates, including collaborations to develop hybrid electric turbogenerators for Advanced Air Mobility and work on integrated hybrid electric propulsion systems. Announcements about defense propulsion, such as the use of F110 engines and propulsion support for autonomous VTOL aircraft, highlight the company’s presence in military and next‑generation applications.
Additional releases cover corporate actions such as regular quarterly dividend declarations, leadership changes disclosed via SEC filings, and community and education initiatives, including scholarship programs supported by the GE Aerospace Foundation. For readers tracking GE Aerospace, this news page offers a centralized view of customer deals, technology milestones, governance developments, and strategic partnerships. Bookmark this page to monitor how GE Aerospace’s engine programs, services, and collaborations evolve over time.
GE (NYSE: GE) has announced a tender offer to purchase up to $7 billion in outstanding securities, part of its strategy to reduce debt as it moves towards creating three standalone companies, including GE HealthCare. The tender offer is set to expire on December 7, 2022, with an early participation date on November 22, 2022. Holders of the securities can receive total consideration that includes accrued interest. GE intends to use proceeds from new debt securities for debt repayment, supporting its leverage reduction efforts.
GE Healthcare’s DaTscan has received FDA approval for the diagnosis of Dementia with Lewy Bodies (DLB), expanding its established use in evaluating Parkinsonian syndromes. This marks a significant advancement, as DLB is often misdiagnosed, with up to 70% of cases mistaken for Alzheimer’s Disease. The expanded use of DaTscan aims to enhance diagnostic accuracy for one in five dementia patients suffering from DLB, potentially leading to better treatment paths. Over one million DaTscan doses have been administered globally, underscoring its market leadership in radiopharmaceutical diagnostics.
GE’s Grid Solutions and Power Conversion businesses have been contracted by Baker Hughes to provide high-voltage equipment and an energy management system for Venture Global’s Plaquemines LNG export facility in Louisiana. This project aims to enhance the efficiency and reliability of the liquefaction process, following a prior collaboration on the Calcasieu Pass project. GE will supply critical components including 145 kV gas-insulated switchgear, integrated protection systems, and high-voltage transformers, bolstering the company’s role in the energy transition.
Current Chemicals has launched market-ready miniLED LCD displays utilizing phosphor film at the Phosphors & Quantum Dots Industry Forum in San Francisco. These displays feature high contrast and a wide color gamut for an enhanced viewing experience. The displays incorporate Current's patented TriGain® KSF/PFS red phosphor and newly developed JADEluxe™ narrow-band green phosphor. This innovation aims to impact both current and future display technologies. The event takes place from October 26-27, 2022.
GE Healthcare and Accuray Incorporated (NASDAQ: ARAY) have signed a global commercial collaboration agreement aimed at enhancing personalized cancer treatment. The partnership will merge GE's advanced diagnostic tools with Accuray's radiation therapy technologies to improve patient care throughout the cancer journey, focusing initially on lung and brain cancers. This collaboration promotes early detection and precise treatment delivery, while also emphasizing digitalization and interoperability in healthcare systems. The companies aim to increase access to effective radiation therapy for cancer patients globally.
GE Healthcare leads the US FDA's updated list of AI-enabled medical devices with 42 authorizations, reflecting the company's robust AI strategy aimed at enhancing healthcare efficiency, outcomes, and interoperability. The company utilizes its Edison Health Services platform to integrate data from diverse sources, supporting clinical applications. Innovations like Air Recon DL and Critical Care Suite 2.0 exemplify GE's commitment to improving patient care through AI-driven solutions. With $17.7 billion in revenue and a global workforce of around 48,000, GE Healthcare aims to revolutionize healthcare services through data-driven technology.
GE Healthcare and AMC Health have announced a partnership to enhance Remote Patient Monitoring (RPM) capabilities. This collaboration extends patient care from hospitals to home environments, utilizing GE's acute monitoring technology and AMC's FDA-cleared RPM solutions. With over 133 million Americans living with chronic diseases, this initiative aims to reduce hospital admissions by allowing real-time monitoring and analytics for better patient management. The RPM solutions will integrate with GE's existing healthcare platforms, aiming to deliver comprehensive care beyond hospital walls.
GE Healthcare has partnered with Tribun Health to enhance digital pathology solutions for oncology. This collaboration will integrate Tribun's Health Suite into GE's products, notably improving data management through the vendor neutral archive (VNA) and Edison Datalogue. The goal is to streamline the oncology care pathway, facilitating prompt and accurate pathology reporting via AI technology. As global oncology cases rise, this partnership addresses the pressing need for efficient data-driven healthcare solutions.
GE Digital has unveiled FlightPulse® for Business Jets at the NBAA-BACE, an advanced Electronic Flight Bag application aimed at enhancing operational safety for pilots. Developed in collaboration with Gulfstream Aerospace, this software provides critical flight data, enabling informed decision-making. Features include pre- and post-flight analytics tools designed for user-friendliness. FlightPulse integrates with GE's existing safety programs, boosting data access for more than 350 corporate flight departments. The product showcases GE Digital's commitment to improving aviation safety and efficiency.
Telix Pharmaceuticals has announced a strategic agreement with GE Healthcare to integrate their investigational PET imaging radiotracers, TLX250-CDx and [18F]-FLac, into GE's immuno-diagnostic portfolio. These tracers evaluate tumor metabolism, aiding in patient selection for immunotherapy. The collaboration aims to enhance clinical research offerings, with GE responsible for marketing while Telix manages product development. This five-year agreement could significantly influence oncology treatments by improving therapy selection and monitoring.
FAQ
What is the current stock price of GE Aerospace (GE)?
What is the market cap of GE Aerospace (GE)?
